<DOC>
	<DOCNO>NCT00482365</DOCNO>
	<brief_summary>RATIONALE : Gathering health information patient liver cancer time may help doctor learn disease may help study cancer future . PURPOSE : This clinical trial develop national registry blood bank patient liver cancer .</brief_summary>
	<brief_title>National Registry Blood Bank Patients With Liver Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate etiologic factor associate hepatocellular carcinoma ( HCC ) different ethnic group different part United States develop national registry HCC patient . - Survey stage potential treatability HCC patient refer Vanderbilt University Hospital . - Establish serum repository registry patient sample use future study pathogenesis chronic liver disease HCC develop well diagnostic test . OUTLINE : This multicenter , cross-sectional database study . Data collect patient diagnose hepatocellular carcinoma Vanderbilt University Medical Center participate hospital liver transplantation center around country inclusion national registry liver cancer patient . Registry data collect baseline every 6 month 5 year . The data derive investigator interview patient medical chart review routine medical care provide course study . Data collect study site enter master database include information patient demographic , diagnosis stag detail , treatment history , result laboratory study , patient outcomes . Information derive registry available investigator study site . Patients registry also undergo blood collection baseline . Blood sample store serum repository evaluation future study relate liver disease , viral hepatitis , liver cancer . A biological marker may analyze squamous cell carcinoma antigen immune complex ( SCCA-IC ) . PROJECTED ACCRUAL : A total 1,500 patient accrue Vanderbilt University Medical Center study 2,000 patient national study .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Diagnosis hepatocellular carcinoma participate institution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>adult primary hepatocellular carcinoma</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>localize resectable adult primary liver cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
</DOC>